Massachusetts H1368 mandates Medicaid coverage for rapid whole genome sequencing for eligible beneficiaries.

Massachusetts H1368 requires the Executive Office of Health and Human Services to ensure Medicaid coverage for rapid whole genome sequencing for eligible beneficiaries. This coverage applies when specific clinical criteria are met, such as congenital anomalies, abnormal diagnostic test results, or a family genetic history related to the patient's condition. Rapid whole genome sequencing is defined as an investigation of the entire human genome that returns preliminary results within 5 days and final results within 14 days.

Massachusetts H1368 mandates Medicaid coverage for rapid whole genome sequencing for eligible beneficiaries.

Massachusetts H1368 requires the Executive Office of Health and Human Services to ensure Medicaid coverage for rapid whole genome sequencing for eligible beneficiaries. This coverage applies when specific clinical criteria are met, such as congenital anomalies, abnormal diagnostic test results, or a family genetic history related to the patient's condition. Rapid whole genome sequencing is defined as an investigation of the entire human genome that returns preliminary results within 5 days and final results within 14 days.